Laurus Labs responded to NSE queries regarding technical filing delays and XBRL discrepancies in its Q2 FY26 results.
The company reported strong Q2 FY25 standalone net profit of ₹215.67 crore and consolidated net profit of ₹193.75 crore.
Board approved interim dividend of ₹0.80 per share and disclosed ongoing corporate restructuring through NCLT.
Auditors provided unmodified review reports for both standalone and consolidated financial results for the period.